Who is EbMCsquared

Advancing health and well-being
for the benefit of humankind

The team

Tess established EbMCsquared CiC, a non-profit company, in March 2021 in response to the tremendous need for independent and objective health care research and provision, arising out of the Covid-19 health emergency. Since 2013, Tess has run Evidence-based Medicine Consultancy Ltd, which specialises in providing evidence to underpin clinical practice guidelines. Her experience as a clinician and researcher in low, middle and high-income country settings informed her vision for EbMCsquared, promoting good health and wellbeing through the concept of ‘first, do no harm’.

With a first class honours degree in biochemistry & toxicology & a research-based PhD in respiratory pharmacology, Mike has spent 31 years working in pharmaceutical R&D, mostly in innovative medicines’ development for disorders of the lung & skin. He was a Vice President and CSO for Allergy and Respiratory Diseases at Pfizer for 16 years & CEO and Founder of the biotech, Ziarco Pharma Ltd.

Dr Dana Flavin is the president of CollMed, a non-profit research foundation for Collaborative Research and medicine in the USA. She is one of the leading Doctors in Integrative Cancer and has doctoral disciplines in Chemistry, Pharmacology, Toxicology, Biochemistry and Medicine as well as becoming a Naturopathic doctor out of academic curiosity. She was the assistant to the Director of Toxicology at the FDA in Washington, science adviser to the president of the Nutrition Foundation and holds an Honorary Professorship at the Leicester School of Pharmacy, De Montfort University.

Katherine has 25 years’ experience in and around medicines development. With a background in pharmacology and epidemiology, she has worked in international clinical trials management in Europe, in the training of researchers in the ethical and legal requirements for clinical trials and in consultancy. In 2015 she founded Epidemica Ltd, a systematic reviews consultancy.